InvestorsHub Logo
Post# of 251747
Next 10
Followers 828
Posts 119587
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 207357

Monday, 06/26/2017 10:01:15 AM

Monday, June 26, 2017 10:01:15 AM

Post# of 251747
OSE.PA -24% on enrollment pause in phase-3 NSCLC trial for futility assessment:

https://finance.yahoo.com/news/ose-immunotherapeutics-announces-temporary-pause-190000584.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.